Veracity Capital’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$632K Buy
7,419
+5
+0.1% +$359 0.17% 116
2026
Q1
$489K Hold
7,414
0.17% 119
2025
Q4
$471K Hold
7,414
0.14% 149
2025
Q3
$407K Hold
7,414
0.13% 163
2025
Q2
$245K Hold
7,414
0.09% 207
2025
Q1
$298K Hold
7,414
0.12% 172
2024
Q4
$349K Hold
7,414
0.13% 158
2024
Q3
$391K Hold
7,414
0.15% 142
2024
Q2
$402K Sell
7,414
-14
-0.2% -$845 0.17% 126
2024
Q1
$521K Sell
7,428
-50
-0.7% -$3.87K 0.2% 114
2023
Q4
$624K Buy
7,478
+44
+0.6% +$1.59K 0.25% 88
2023
Q3
$219K Sell
7,434
-72
-1% -$2.4K 0.1% 178
2023
Q2
$245K Buy
7,506
+32
+0.4% +$1.18K 0.1% 188
2023
Q1
$263K Sell
7,474
-34
-0.5% -$1.39K 0.12% 168
2022
Q4
$344K Buy
7,508
+7
+0.1% +$301 0.16% 131
2022
Q3
$363K Sell
7,501
-820
-10% -$39.5K 0.2% 112
2022
Q2
$327K Hold
8,321
0.17% 130
2022
Q1
$306K Hold
8,321
0.13% 171
2021
Q4
$379K Hold
8,321
0.15% 148
2021
Q3
$297K Buy
+8,321
New +$245K 0.13% 178
2021
Q2
Sell
-19,430
Closed -$452K 266
2021
Q1
$452K Buy
+19,430
New +$415K 0.1% 202

Other funds holding CYTK